Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Res Social Adm Pharm. 2021 Sep 20;18(7):3191–3198. doi: 10.1016/j.sapharm.2021.09.005

Examining adolescents’ opioid knowledge and likelihood to Utilize an educational game to promote medication safety

Olufunmilola Abraham a,*, Claire A Rosenberger a, Jen Birstler b, Kathleen Tierney a
PMCID: PMC9536463  NIHMSID: NIHMS1833732  PMID: 34561172

Abstract

Background:

Adolescents’ knowledge on opioids is seldom studied, despite the fact young people are one of the groups most affected by the opioid crisis within the United States. There is a need to understand adolescents’ perceptions about opioid misuse and safety to create the necessary tools to educate adolescents on safe opioid use.

Objective:

This study sought to understand adolescents’ knowledge and perceptions of opioid use and safety as well as their receptiveness to using an educational game for improving medication safety knowledge.

Methods:

A 67-item survey was developed to assess adolescents’ opioid perceptions, knowledge, and the likelihood of an educational game to enhance their opioid medication safety. A nationally representative sample of US adolescents aged 12 to18 were recruited via a Qualtrics participant panel to complete the online survey from October through November 2020. Survey questions were grouped into 10 categories to represent key concepts and summarized into concept scores. Concepts were described through means, median, and range as well as percent correct for individual questions. Differences between groups were assessed using Kruskal-Wallis tests. Concept scores and their relation to the participant’s age were described by the Pearson’s correlation coefficient and the linear model coefficient.

Results:

A total of 592 responses were analyzed. Male and older participants reported greater perceived opioid knowledge than females. White participants reported higher rates of perceived opioid knowledge, behavioral intent, and knowledge of safe medication disposal than any other racial group. About 80% of participants were receptive to the use of an educational game to increase their opioid safety knowledge.

Conclusions:

There are discrepancies in adolescents’ knowledge on opioid safety and harm amongst genders, race, and age. Study findings support the use of an educational game to increase adolescents’ opioid knowledge. Future studies should design an educational game intended for a diverse audience.

Keywords: Adolescents, Opioid medication safety, Educational game, Opioid crisis, Naloxone (Narcan®)

1. Introduction

In 2019, approximately 50,000 people in the United States died from an opioid-related overdose, and 7.6% of adolescents reported opioid misuse.1,2 Pain is one of the main reasons individuals in the United States seek healthcare, and in 2016, the most reported cause for opioid misuse was to relieve physical pain.3,4 Adolescents with a history of chronic pain are more likely to misuse opioids; 84%–88% of adolescents report using opioids in ways other than how they were prescribed to help treat pain.5,6 Additionally, adolescents prescribed opioids before 12th grade are at a significant risk of misusing opioids later in life.2,7,8 One potential reason for adolescent opioid misuse is the inconsistent information provided on how to treat pain and what constitutes misuse of opioid medications. The Centers for Disease Control and Prevention (CDC) describes various actions that refer to opioid misuse, such as using someone else’s prescription opioid medication, consuming opioids in a way other than as directed on their prescription, and sharing opioid medications with others, but the CDC does not provide a clear definition for opioid misuse.9 In addition, the CDC does not have guidelines or recommendations for pain management in children.10 Furthermore, prior research found that 64% of clinicians do not have a protocol for prescribing pain management.11 There needs to be a clear and easy way to educate adolescents on how to use opioids correctly and what signifies misuse, so they can make informed decisions when prescribed opioid medications.

1.1. Opioid knowledge among teens

To use prescription medications safely and responsibly, knowledge on how to properly use, store, and dispose of medicines is critical. Studies have shown that adolescents have limited knowledge about opioid medications.1216 Adolescents have a basic understanding of opioids and the consequences of misuse, but they are often unable to identify which medications are opioids.12 Adolescents are knowledgeable about prescription opioid use, but they are uninformed of their addictive potential and the related risks of overdose.15 Most adolescents are familiar with the behavioral signs of opioid addiction, but they are unaware of the accessibility of naloxone (Narcan®) to reverse overdoses.16 Additionally, adolescents report contradictory perceptions about opioid medications. About 80% of surveyed adolescents recognized short-term use of opioids can cause addiction; however, almost half reported they did not think they would become addicted after short-term opioid use.12 Most adolescents are aware of the potential dangers of opioids and the importance of keeping them out of reach of children.16 Nevertheless, they report sharing, stealing, and improperly storing prescription medications.16

1.2. Gender, age, and race differences

Gender, age, and race are important factors that influence opioid misuse and/or the lack of knowledge on how to correctly use the medication. Differences among genders for opioid knowledge and use are primarily due to external factors such as parenting styles, peer pressure, and opioid prescription practices. Parental supervision and guidance often differ between males and females and can lead to parents being less aware of their child’s behavior and/or make them think differently about a child’s actions towards opioid misuse.17 Opioid misuse is also influenced by social factors such as peer pressure, which can vary by gender.18 Furthermore, females are twice as likely than males to be prescribed opioids.19 Women report more chronic conditions that cause pain, which can be associated with higher prescription rates of opioids.19 Race is also a factor to consider when examining opioids use and knowledge. Racial and ethnic minorities are at a higher risk of receiving inadequate treatment for pain than those who are in the majority.20 One study found White children were prescribed fewer opioids after having a medical procedure than Black children, which could make them less likely to use opioids long-term.2123 Additionally, the prevalence of misusing opioids is higher among Hispanic adolescents than Black or White adolescents, with Hispanic females reporting the most misuse.24

There are also age differences when it comes to opioid use, knowledge, and perceptions.24 Prescription opioid misuse usually begins in adolescence and peaks at ages 18–21 years.25 However, individuals younger than 25 years believe they will not become addicted to prescription opioids after short-term use, despite research showing they are in an at-risk age group for opioid misuse and addiction.12 Additionally, a national survey found the number of adolescents reporting having ever misused prescription pain medicine, including taking the drug without a doctor’s prescription or differently than how they were prescribed, is higher among 11th-grade (15.4%) and 12th-grade (17.0%) than 9th-grade (10.9%) students, suggesting older students are more likely to misuse opioids than their younger peers.24

1.3. Existing educational opioid programs

With the opioid epidemic increasingly affecting adolescents, new educational interventions have been developed to support adolescents’ learning and understanding of opioids. For example, ‘Opioid Lifeline’ developed This is (Not) About Drugs, one of the first youth-focused educational programs aimed at addressing the opioid health crisis.26 It educates adolescents in a classroom setting on how addiction can stem from misuse, symptoms of an overdose, the use of naloxone (Narcan®), and provided resources for helping adolescents use opioids correctly.26 Other organizations, such as ‘Rx for Addiction’, have created educational programs focused on medication safety, signs of misuse, withdrawal, and overdose through role-play, case scenarios, and social media.27 While there are several interventions that have been shown to be helpful for adolescents, there are limited studies that measure adolescents’ receptiveness for an educational game on promoting safe medication use.28

Opioid misuse in adolescents is not adequately addressed in current literature. Few studies have examined adolescents’ knowledge and perceptions of opioids and how demographic characteristics affect what information they receive. Furthermore, a limited number of studies have recruited a nationally representative sample of US adolescents when examining opioid knowledge; rather prior studies have typically recruited a national sample to study adult populations.7,29 There is a need to understand adolescents’ knowledge and perceptions about opioids to create the necessary tools to educate youth on proper opioid use and safety. This study sought to examine adolescents’ knowledge and perceptions of opioid use and safety as well as their receptiveness to using an educational game for improving medication safety knowledge.

2. Methods

2.1. Survey design

Study team members designed a survey that consisted of close-ended questions with “Yes,” “No,” and “Don’t know” options or a five-point Likert scale (Appendix A). The survey collected participants’ perceptions on severity and susceptibility of opioid misuse, as well as the use, storage, and disposal of prescription opioids. The survey included questions about participants’ attitudes and perspectives regarding opioids and if they thought an educational game would improve their knowledge about opioid medication safety. The survey also collected participants’ demographic information, such as age, grade, gender, race, and ethnicity.

Survey questions were adapted from other validated surveys. Questions related to the safe storage and disposal of opioids were modified from a survey assessing the misuse of prescription opioid use within the state of Wisconsin and altered to assess the perceptions and knowledge of misuse, safety, storage, and disposal of prescription opioids in adolescents.17,30 Questions that involved self-efficacy were adapted from the Medication Understanding and Use Self-Efficacy (MUSE) scale, a validated tool that measures both understanding and self-efficacy in prescription medication use.31 Questions related to participants’ self-efficacy regarding overall medication safety were adapted from a previous study that examined adolescent workplace safety and health knowledge as well as questions related to the participant’s behavioral intent regarding prescription opioid use.32 Questions associated with opioid misuse behaviors were created by the research team and were pilot tested within a study that investigated teens’ knowledge and perceptions on prescription opioid misuse.14 Questions about naloxone knowledge were adapted from a Maryland Opioid Survey Summary Report which examined the public’s opinions on prescription opioids—specifically, their perceptions, attitudes, beliefs, and practices.33

2.2. Recruitment and participants

This study was approved by the University of Wisconsin Institutional Review Board. The survey was open from October to November 2020. A nationally representative sample was recruited via a Qualtrics participant panel. Persons were eligible if they were 12–18 years, lived in the United States, and could speak and understand English. Eligibility was determined (1) from previous studies that examined children’s perspectives on medication related topics who were 7–17 years and spoke English,34,35 (2) from initial community engagement with key stakeholders such as school administrators (principals, health and science teachers, and school nurses) indicating the need to begin opioid education as early as middle schools and progress into high schools, and (3) because adolescents aged 12–18 years are capable of more complex thinking related to medication use.36 Thus, adolescents 12–18 years were chosen for the participant age range. Parents of potential participants were screened for eligibility and asked to provide consent for their child to participate in the study and child assent was then obtained. Once both parent and child consented, the parent’s contact information was collected. Parents were directed to the online survey for the child to complete independently. A $10 Amazon gift card was emailed to the parent’s email address upon completion of the online survey by the child participant.

2.3. Data analysis

2.3.1. Concept scores

The survey questions were divided into 10 categories to represent key concepts and summarized into concept scores. Five of the concepts consisted entirely of Likert questions with responses graded as five for the most desirable response to one for the least desirable (e.g., strongly agree’ to ‘strongly disagree’). Survey questions within each of these concepts were summarized by the mean. The remaining five concepts consisted of multiple-choice knowledge questions with one response as correct and the remaining as incorrect. Questions within each of these concepts were summarized by the percent correct responses and range from zero to one.

2.4. Categorical analysis

Concept scores were described through means (SD), median [IQR], and range across all participants, stratified by gender (male, female), school (middle school, high school), and race (white non-Hispanic, Black or African American non-Hispanic, Hispanic, and all other groups). Differences between groups were assessed using Kruskal-Wallis tests.

2.5. Continuous analysis

The relationship between concept scores and the participant’s age were described by the Pearson’s correlation coefficient (95% confidence interval) and the linear model coefficient (95% confidence interval) and assessed by the correlation test p-value. Linear models were used to estimate the change in a concept score per year of age. Models were not adjusted for any additional covariates. For concept scores that were statistically significant, the relationship between individual questions and age were assessed using Pearson’s correlation tests for Likert questions and Mann-Whitney tests for knowledge questions.

2.6. P-value corrections

Significance was assessed at the alpha = 0.05 level. Despite the large number of tests, the analysis was descriptive in nature, so no p-value corrections were made to account for the inflated type 1 error rate. Analysis was conducted using R version 4.0.4.

3. Results

Overall, 1261 responses were collected. Of these responses, 659 were unfinished or had missed attention questions and were excluded from data analysis. A total of 602 participants were confirmed to have completed the survey; however, two were found to be duplicates, and eight had international identifiers and were also excluded. The remaining 592 responses were used for statistical analysis. Descriptions of concept scores excluded four submissions from non-binary participants from analysis by gender.

3.1. Demographics

Half of the study participants were female (50%), and the mean age was 14.67 (SD = 1.68). The sample’s race/ethnicity mirrored that of the US Census numbers. Characteristics of study participants are shown in Table 1.

Table 1.

Participant demographic characteristics.

Gradea n (%)
7th 96 (16)
8th 95 (16)
9th 123 (21)
10th 104 (18)
11th 82 (14)
12th 89 (15)
Age, years
Mean (SD) 14.67 (1.68)
Number of household members under the age of 18 years c
0 142
1 227
2 155
3 or more 66
Did not answer 2
Mean (SD) 1.31 (1.13)
Gender b
Female 296 (50)
Male 292 (49.32)
Nonbinary 4 (0.68)
Race/Ethnicity a
White or Caucasian 342 (57.77)
Black or African American 90 (15.2)
Hispanic or Latinx 46 (7.77)
Asian 26 (4.39)
American Indian or Alaskan native 6 (1.01)
Native Hawaiian or Other Pacific Islander 1 (0.17)
More than one selected 76 (12.84)
Other please specify 3 (0.51)
a

Responses to demographic questions were requested but not required. Missing status indicates participants did not answer the demographic question.

b

Due to the small sample size, responses of ‘nonbinary’ were excluded from analysis examining the effects of gender, with a total of 588 used instead of 592.

c

If the participant lived in more than one home, they were asked to answer regarding the home they spent the most time in. The participant was asked to not include themselves in the total number of people living in their home under the age of 18.

3.2. Gender

Male participants reported greater perceived knowledge (M = 3.03 (SD = 1.03)) than female participants (2.78 (1.06), p = 0.003). Female participants scored greater on the misuse harm scale (4.34 (0.75)) than male participants (4.22 (0.82), p = 0.044). Male participants scored higher on the opioid knowledge scale (0.87 (0.17)) than female participants (0.84 (0.18), p = 0.048) as shown in Table 2.

Table 2.

Concept scores amongst participants.

Variable Self-efficacy: MUSE Self-efficacy: Learning Objectives Perceived Knowledge Misuse Harm Behavioral Intent Safe Storage Safe Disposal Opioid Knowledge Narcan® Knowledge Misuse Behavior
Overall
N 592 592 592 591 592 592 592 592 290 592
Mean (SD) 4.29 (0.77) 3.98 (0.79) 2.90 (1.05) 4.28 (0.80) 3.38 (0.64) 0.92 (0.19) 0.88 (0.20) 0.85 (0.18) 0.79 (0.31) 0.62 (0.29)
Gender
Female, mean (SD) 4.35 (0.72) 4.00 (0.80) 2.78 (1.06) 4.34 (0.75) 3.39 (0.62) 0.92 (0.19) 0.87 (0.21) 0.84 (0.18) 0.79 (0.31) 0.62 (0.28)
Male, mean (SD) 4.23 (0.81) 3.95 (0.78) 3.03 (1.03) 4.22 (0.82) 3.38 (0.66) 0.92 (0.19) 0.89 (0.18) 0.87 (0.17) 0.80 (0.31) 0.61 (0.30)
Kruskal-Wallis p-value 0.105 0.299 0.003 0.044 0.752 0.972 0.139 0.048 0.503 0.755
Race
White or Caucasian, mean (SD) 4.34 (0.73) 4.01 (0.76) 3.14 (1.00) 4.25 (0.76) 3.44 (0.63) 0.93 (0.16) 0.90 (0.18) 0.88 (0.16) 0.81 (0.30) 0.63 (0.28)
Black or African American, mean (SD) 4.25 (0.81) 4.03 (0.82) 2.78 (1.02) 4.38 (0.78) 3.40 (0.59) 0.94 (0.18) 0.88 (0.20) 0.86 (0.18) 0.79 (0.31) 0.63 (0.30)
Hispanic or Latinx, mean (SD) 4.24 (0.81) 3.95 (0.78) 2.60 (1.11) 4.23 (0.94) 3.30 (0.67) 0.88 (0.26) 0.84 (0.24) 0.80 (0.23) 0.73 (0.35) 0.59 (0.31)
Other or missing, mean (SD) 4.15 (0.80) 3.78 (0.90) 2.23 (0.83) 4.34 (0.77) 3.12 (0.63) 0.92 (0.20) 0.85 (0.24) 0.80 (0.17) 0.74 (0.32) 0.61 (0.31)
Kruskal-Wallis p-value 0.306 0.282 < 0.001 0.213 0.005 0.426 0.049 < 0.001 0.432 0.767
School
High school, mean (SD) 4.30 (0.77) 4.00 (0.80) 2.96 (1.05) 4.32 (0.77) 3.39 (0.62) 0.92 (0.20) 0.88 (0.20) 0.87 (0.15) 0.81 (0.30) 0.62 (0.29)
Middle school, mean (SD) 4.28 (0.77) 3.93 (0.77) 2.79 (1.03) 4.20 (0.86) 3.36 (0.69) 0.93 (0.16) 0.88 (0.20) 0.82 (0.21) 0.76 (0.33) 0.62 (0.29)
Kruskal-Wallis p-value 0.584 0.228 0.066 0.155 0.369 0.901 0.599 0.046 0.286 0.923
Grade
Correlation coefficient 0.05 0.06 0.1 0.09 0.05 0.01 0.03 0.13 0 0.01
95% CI −0.03 to 0.13 −0.02 to 0.14 0.02 to 0.18 0.01 to 0.17 −0.03 to 0.13 −0.08 to 0.09 −0.05 to 0.11 0.05 to 0.21 −0.11 to 0.12 −0.07 to 0.09
Pearson’s correlation p-value 0.21 0.142 0.011 0.03 0.224 0.89 0.473 0.001 0.956 0.775
Age
Correlation coefficient 0.05 0.06 0.11 0.1 0.07 0.02 0.06 0.13 0.05 0.03
95% CI −0.03 to 0.13 −0.02 to 0.14 0.03 to 0.19 0.02 to 0.18 −0.01 to 0.15 −0.06 to 0.10 −0.02 to 0.14 0.05 to 0.21 −0.07 to 0.16 −0.05 to 0.11
Pearson’s correlation p-value 0.214 0.132 0.007 0.013 0.102 0.637 0.142 0.001 0.438 0.415
a

Bolded values indicate significant findings.

3.3. School

High school students scored higher on the opioid knowledge scale (0.87 (0.15)) than middle school students (0.82 (0.21), p = 0.046).

3.4. Race

Comparisons between participants identifying as White or Caucasian, Black or African American, Hispanic or Latinx, and those identifying as any other group are shown in Table 2. Overall, participants identifying as White or Caucasian reported higher rates of perceived opioid knowledge, behavioral intent, safe medication disposal, and overall opioid knowledge than those who identified as African American, Hispanic or Latinx, or any other group.

3.5. Age

Misuse harm (rho = 0.10, 95% CI 0.02 to 0.18, p = 0.013), perceived knowledge (rho = 0.11, 95% CI 0.03 to 0.19, p = 0.007), and opioid knowledge (rho = 0.13, 95% CI 0.05 to 0.21, p = 0.001) were positively associated with age.

3.6. Opioid perceptions and educational intervention

Most participants (78%) stated the opioid crisis was harming teenagers in the United States and 83.1% recognized it was not proper to take someone else’s opioid medication if you have had the same prescription in the past. When participants were asked if they had heard of the drug naloxone (Narcan®), 290 (49%) reported “yes” and of those 290 respondents, 221 (76.2%) recognized that it was used to reverse opioid overdoses. Additionally, when participants were asked “after playing an educational video game, would you feel as though your knowledge about opioid medication safety would increase?” 80% reported “yes” (Table 3).

Table 3.

Survey questions of significance within key concepts.

Question Response (N, Percent)
Yes No Don’t Know
Is the opioid crisis harming teenagers in the U.S.?a
462 (78%) 31 (5%) 99 (17%)
After playing an educational video game, would you feel as though your knowledge about opioid medication safety would increase?
471 (80%) 121 (20%)
Is it okay to take someone else’s opioid medication if you have had the same prescription in the past? b
66 (11.1%) 492 (83.1%) 34 (5.7%)
Have you heard of the drug naloxone (Narcan®)?
290 (49%) 302 (51%)
a

The correct answer to this question is “yes”.

b

The correct answer to this question is “no”.

4. Discussion

In this study, a nationally representative sample of adolescents were recruited, and an online survey was used to quantitatively measure their knowledge and perceptions on opioid use, storage, and disposal, as well as their receptivity for the use of an educational game to increase opioid knowledge. There was a difference in knowledge for opioid use and safety among genders, race, level in school, and age, which is consistent with current literature.19,20,22 Additionally, participants stated that playing an educational game would increase their knowledge about opioid medication safety.

Racial/ethnic minorities and underserved populations are underrepresented in medical literature, and there is a need to explore their knowledge, understanding, and experiences regarding opioid use and safety.6,16,1921 This study sought to contribute to this need by recruiting a nationally representative sample of adolescents. Results showed female participants scored greater on the misuse harm scale than male participants, which is in line with existing literature.37 White or Caucasian participants reported higher rates of perceived opioid knowledge, behavioral intent, safe medication disposal, and opioid knowledge than those who identified as African American, Hispanic or Latinx, or any other group. Additionally, misuse harm, perceived knowledge, and opioid knowledge were positively associated with age. Results showed female participants scored greater on the misuse harm scale than male participants, which is in line with existing literature.37 Findings suggest opportunities for accessible health education to provide adolescents, especially minorities, with information about opioid use, overdose reversal, and disposal options. Results from this study also support the use of an educational game to increase adolescents’ opioid knowledge. An education game may serve as an engaging and interactive approach for parents, healthcare professionals, or schoolteachers to educate youth on prescription opioid safety when these medications are prescribed in clinics and dispensed pharmacies.

Previous literature suggests that factors such as family members, peers, and healthcare professional influence can increase the risk of opioid misuse and should be addressed when designing an educational game.38 There is a strong association between parents who misuse opioids and their adolescent misusing opioids, both intentionally and accidently; one-third of adolescents who misuse opioids report a family member as the source of the drug.39 Additionally, studies show parents want to help their children relieve pain, even if that means giving them opioids in greater doses or frequency.40 Moreover, there is a significant correlation between lifetime opioid dependence and having a prescription opioid in the household medicine cabinet.41 Approximately 85% of adolescents report getting opioids from family members who incorrectly stored prescribed medications.42 Studies also found proper storage of opioids is more common in households with children under the age of seven, even though adolescents are more likely to misuse opioids and share them with others.27,4345 Hence, an educational game should address these common issues related to responsible opioid use in homes and appropriate storage and disposal mechanisms.

Future studies should create and investigate the use of an educational game that allows both the adolescent and their parent to learn about safe opioid use. Based on the results from this study, educational content needs to focus on opioid knowledge, opioid misuse, behavioral intent, medication disposal, and naloxone (Narcan®) use. Researchers should obtain feedback from adolescents, in the form of surveys and focus groups, on what they would like to see in an educational game designed for medication safety as well as professionals’ perspectives on how to implement an educational game for use in homes with youth and adoption by healthcare and school settings. The educational game would need to be designed to connect with a diverse audience and with potential for use in schools as part of health or science classes, and in healthcare settings such as clinics and pharmacies where adolescents are prescribed and dispensed opioids medications.

4.1. Limitations

This study relied on the use of self-report to collect information and trusted participants to give honest responses. Such study designs are limited by forgetfulness, dishonesty, fraud, and reporting-bias. This study design also relied on trusting the parent to allow their child to fill out the survey, on their own, and not influence their responses. To ensure accuracy, another national survey should be distributed in a way that confirms adolescents are the ones taking the survey and their parents are not influencing their responses. Furthermore, a focus group or interview could be incorporated, especially when asking the question “After playing an educational video game, would you feel as though your knowledge about opioid medication safety would increase?” so participants could elaborate on their responses and what they would like to see in the educational game.

4.2. Implications for pharmacy practice

The Pediatric Pharmacy Advocacy Group recommends pharmacists educate adolescents and their families about proper administration, storage, and disposal of opioids and when to prescribe naloxone (Narcan®).46 Pharmacists can play a critical role in reducing the number of opioid misuse cases each year by adolescents through empowering parents to talk with their children about prescription opioid use and medication safety. Given that adolescents report parents as useful resources for information about opioid safety, especially mothers, a clear opportunity exists to positively impact family communication and practices around opioid safety in a pharmacy setting.47 Thus, a family-driven intervention is essential.

Educational video games have been successful in effecting behavior change and other health-related issues for adolescents.48 A novel and engaging educational game can be used as an interactive tool to promote and facilitate parent-child conversations about prescription opioid medication safety. Availability of the game during dispensing of opioid medications to families with children in pharmacies where the pharmacist is present will allow pharmacists to foster conversations with their adolescent patients and family members. The game may also prompt parents and children to ask pharmacists’ medication-related questions they may not have thought about before playing the game, such as how to correctly store and dispose of opioid medications.

5. Conclusion

This study assessed adolescents’ opioid knowledge and the likelihood of an educational game to promote medication safety. Results showed a difference in knowledge for opioid use and safety among genders, race, school level, and age. Findings support the use of an educational game to increase adolescent’s opioid knowledge. An educational game that incorporates adolescents’ family members, peers, and healthcare professionals’ feedback is essential to decreasing the number of adolescents who report misusing opioids each year. Future studies should investigate the use of an educational game to educate adolescents on opioid use, safety, storage, disposal, and how to reverse an opioid overdose.

Acknowledgements

The authors appreciate Dr. Laura Stephenson from the University of Wisconsin-Madison for her assistance with creating and managing the IRB protocol, survey development, and data collection. We would also like to thank Lisa Szela from the University of Wisconsin-Madison School of Pharmacy for editing the manuscript and providing feedback throughout the writing process.

Funding

This study was supported by KL2 grant KL2 TR002374-03 and grant UL1TR002373 to UW ICTR by the Clinical and Translational Science Award (CTSA) program, through the NIH National Center for Advancing Translational Sciences (NCATS). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.

Abbreviations:

CDC

The Centers for Disease Control and Prevention

MUSE

Medication Understanding and Use Self-Efficacy scale

Appendix A. The 67-item survey with questions, concepts, and response types.

Question Concept Response Type
Can opioid medications make you dizzy or sleepy even when they are taken as prescribed by your doctor?
If you do not know how much of an opioid medication to take, is it ok to ask your friends?
Can taking too much of an opioid medication cause you to pass out?
Is it safe to drive a car or supervise children after you have taken your prescribed amount of opioid medication?
Is constipation a sign of opioid medication dependence or addiction?
Can opioid medications cause harm when not used as prescribed by your doctor?
Can extra opioid medications be shared with your friends if they are in pain?
If you take an opioid medication correctly, can there still be side effects?
Is the opioid crisis harming teenagers in the U.S.?
Opioid knowledge Yes; No; Don’t know
Should prescription opioids be stored … in the medicine cabinet?
Should prescription opioids be stored … in an unlocked drawer or cabinet?
Should prescription opioids be stored … in a purse or handbag?
Should prescription opioids be stored … in a locked place, such as a lock box, safe, or locked drawer?
Safe Storage
Should you get rid of unused prescription opioids by … throwing them in the trash?
Should you get rid of unused prescription opioids by … dropping them off in a disposal box?
Should you get rid of unused prescription opioids by … flushing them down the toilet?
Should you get rid of unused prescription opioids by … putting them in cat litter or coffee grinds?
Should you get rid of unused prescription opioids by … taking them to a pharmacy, doctor, or hospital?
Should you get rid of unused prescription opioids by … putting them down the sink/disposal?
Safe Disposal
How much do you know about … how to use an opioid medication safely?
How much do you know about … what counts as misuse of an opioid medication?
How much do you know about … the harmful effects of misusing opioids?
How much do you know about … how to store opioids safely?
How much do you know about … what you should do in situations involving an opioid overdose?
How much do you know about … how to dispose of opioids safely?
Perceived knowledge Likert: 1, none; 2, a little; 3, some; 4, quite a bit; 5, a great deal
It is easy for me to ask my parent questions about safe opioid use.
It is easy for me to understand my parent’s instructions for using opioids safely.
It is easy for me to understand instructions on how to safely manage opioids.
It is easy for me to get all the information I need about safe opioid use.
Self-Efficacy: MUSE Agreement scale: 1, strongly disagree; 2, slightly disagree; 3, neutral; 4, slightly agree; 5, strongly agree
How confident are you that you can …
use opioid medication as directed?
know where your medication is at all times?
store your medication in a locked area?
dispose of your medication in a drop box?
tell a friend no if they ask to share your medication?
only take medication that was prescribed for you?
encourage others to use opioids safely?
Self-Efficacy: learning objectives Confidence scale: 1, not at all confident; 2, slightly; 3, somewhat; 4, very; 5, extremely confident
How much harm does misuse of opioids do to a person’s … physical health?
How much harm does misuse of opioids do to a person’s … mental health?
How much harm does misuse of opioids do to a person’s … ability to do well in school?
How much harm does misuse of opioids do to a person’s … relationships with their family?
How much harm does misuse of opioids do to a person’s … relationships with their peers or friends?
Misuse harm Likert: 1, none; 2, a little; 3, some; 4, quite a bit; 5, a great deal
Is someone misusing opioids if … they return their unused opioid medication to the pharmacy when it expires?
Is someone misusing opioids if … they use their prescribed opioid after it expires?
Is someone misusing opioids if … they use someone else’s opioid medication?
Is someone misusing opioids if … they use opioids more often than their prescription calls for?
Is someone misusing opioids if … they share their opioid medications with others?
Is someone misusing opioids if … they take their opioid medication for a reason different than what it was prescribed for?
Is it okay to take someone else’s opioid medication if you have had the same prescription in the past?
Misuse behavior Yes; No; Don’t know
Have you heard of the drug naloxone (Narcan)?
(if yes) Is Naloxone (Narcan) used to … reverse only heroin overdoses?
(if yes) Is Naloxone (Narcan) used to … help heroin users detox?
(if yes) Is Naloxone (Narcan) used to … reverse any opioid overdose?
Narcan knowledge Yes; No,
If ‘Yes’ to first question, then ‘Yes; No; Don’t know’ to additional questions.
How likely are you to do the following?
use opioid medication as directed?
know where my medication is at all times?
store my medication in a locked area?
dispose of my medication in a drop box?
share my medication with a friend in need?
take medication that was prescribed for someone else?
encourage others to use opioids safely?
Behavioral intent Likelihood scale: 1, not at all; 2, slightly; 3, somewhat; 4, very; 5, extremely likely
After playing an educational video game, would you feel as though your knowledge about opioid medication safety would increase? Perceived game effect Yes; No
Please select “a great deal.” This question is to make sure you are still paying attention.
This is to make sure you are still paying attention. Please select “somewhat.”
Attention check As directed in the question
Year in school -
Gender
Age
Demographics 7th - 12th grade
1, Female; 2, Male; 3, Transgender; 4, Nonbinary; 5, Other
12–18 years old
How many kids under 18 live in your household? Do not count yourself. Insert Number
Race/ethnicity 1, American Indian or Alaskan Native; 2, Asian; 3, Black or African American; 4, Hispanic or Latinx; 5, Native Hawaiian or Other Pacific Islander; 6, White or Caucasian; 7, Other: Please specify

Footnotes

Declaration of competing interest

None.

CRediT author statement

Olufunmilola Abraham: Conceptualization, Methodology, Writing - Review & Editing Claire A. Rosenberger: Writing - Original Draft, Writing - Review & Editing Jen Birstler: Formal analysis, Writing - Original Draft, Writing - Review & Editing Kathleen Tierney: Writing - Original Draft, Writing - Review & Editing.

Data statement

Due to the sensitive nature of the questions asked in this study, survey respondents were assured raw data would remain confidential and would not be shared.

References

  • 1.Wonder Cdc Centers for Disease Control and prevention. [05.18.21]. https://wonder.cdc.gov Accessed.
  • 2.Groenewald CB. Opioid-prescribing patterns for pediatric patients in the United States. Clin J Pain. 2019;35:515–520. 10.1097/AJP.0000000000000707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.High YRBS. School The center for Disease and prevention. [03.29.21]. https://nccd.cdc.gov/youthonline/App/Results.aspx? Accessed.
  • 4.Key substance use and mental health indicators in the United States: results from the 2016 national survey on drugs and health. [05.18.21]. https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2016/NSDUH-FFR1-2016.htm Accessed.
  • 5.Groenewald CB, Law EF, Fisher E, Beals-Erickson SE, Palermo TM. Associations between adolescent chronic pain and prescription opioid misuse in adulthood. J Pain. 2019;20:28–37. 10.1016/j.jpain.2018.07.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.McCabe SE, West BT, Boyd CJ. Motives for medical misuse of prescription opioids among adolescents. J Pain. 2013;14:1208–1216. 10.1016/j.jpain.2013.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.McCabe SE, West BT, Veliz P, McCabe VV, Stoddard SA, Boyd CJ. Trends in medical and nonmedical use of prescription opioids among US adolescents: 1976–2015. Pediatrics. 2017;139:e20162387. 10.1542/peds.2016-2387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Miech R, Johnston L, O’Malley PM, Keyes KM, Heard K. Prescription opioids in adolescence and future opioid misuse. Pediatrics. 2015;136:e1169–e1177. 10.1542/peds.2015-1364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Abraham O, Thakur T, Brown R. Prescription opioid misuse and the need to promote medication safety among adolescents. Res Soc Adm Pharm. 2019;15:841–844. 10.1016/j.sapharm.2019.01.003. [DOI] [PubMed] [Google Scholar]
  • 10.Napier TC, Persons AL. Using modern neuroscience to inform opioid use and abuse liability in adolescents. Orthop Nurs. 2019;38:166–171. 10.1097/NOR.0000000000000527. [DOI] [PubMed] [Google Scholar]
  • 11.Huang JS, Kuelbs CL. Clinician opioid prescribing practices and patient utilization of prescribed opioids in pediatrics. J Opioid Manag. 2018;14:309–316. 10.5055/jom.2018.0463. [DOI] [PubMed] [Google Scholar]
  • 12.Smillov M, Smith LN, Caballero NS, Cintron C, Toklu HZ. Impact of an educational debate on the knowledge of college students on opioids, and factors affecting their perception about addiction. J Res Pharm. 2019;23:792–796. [Google Scholar]
  • 13.Abraham O, Szela L, Thakur T, Brasel K, Brown R. Adolescents’ perspectives on prescription opioid misuse and medication safety. J Pediatr Pharmacol Therapeut. 2021;26:133–143. 10.5863/1551-6776-26.2.133. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Abraham O, Szela L, Norton D, Stafford H, Hoernke M, Brown R. Adolescents’ awareness about prescription opioid misuse and preferences for educational interventions. J Am Pharmaceut Assoc. 2020;60:978–985. 10.1016/j.japh.2020.07.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Moore SK, Grabinski M, Bessen S, Borodovsky JT, Marsch LA. Web-Based prescription opioid abuse prevention for adolescents: program development and formative evaluation. JMIR Form Res. 2019;3:e12389. 10.2196/12389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Unger JB, Molina GB, Baron MF. Opioid knowledge and perceptions among Hispanic/Latino residents in Los Angeles. Subst Abuse. 2020;1–7. 10.1080/08897077.2020.1806185. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Hyde JS. Gender similarities and differences. Annu Rev Psychol. 2014;65:373–398. 10.1146/annurev-psych-010213-115057. [DOI] [PubMed] [Google Scholar]
  • 18.Chan GC, Kelly AB, Carroll A, Williams JW. Peer drug use and adolescent polysubstance use: do parenting and school factors moderate this association?. Addict Behav. 2017;64:78–81. 10.1016/j.addbeh.2016.08.004. [DOI] [PubMed] [Google Scholar]
  • 19.Simoni-Wastila L The use of abusable prescription drugs: the role of gender. J Womens Health Gend Based Med. 2000;9:289–297. 10.1089/152460900318470. [DOI] [PubMed] [Google Scholar]
  • 20.Pletcher MJ, Kertesz SG, Kohn MA, Gonzales R. Trends in opioid prescribing by race/ethnicity for patients seeking care in US emergency departments. J Am Med Assoc. 2008;299:70–78. 10.1001/jama.2007.64. [DOI] [PubMed] [Google Scholar]
  • 21.Sadhasivam S, Chidambaran V, Ngamprasertwong P, et al. Race and unequal burden of perioperative pain and opioid related adverse effects in children. Pediatrics. 2012; 129:832–838. 10.1542/peds.2011-2607. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Tesler MD, Wilkie DJ, Holzemer WL, Savedra MC. Postoperative analgesics for children and adolescents: prescription and administration. J Pain Symptom Manag. 1994;9(2):85–95. 10.1016/0885-3924(94)90161-9. [DOI] [PubMed] [Google Scholar]
  • 23.Schechter NL, Allen D. Physicians’ attitudes toward pain in children. J Dev Behav Pediatr. 1986;7(6):350–354. [PubMed] [Google Scholar]
  • 24.Kann L, McManus T, Harris WA, et al. Youth risk behavior surveillance - United States, 2017. MMWR Surveill Summ. 2018;67:1–114. 10.15585/mmwr.ss6708a1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Park JY, Wu LT. Sources of misused prescription opioids and their association with prescription opioid use disorder in the United States: sex and Age Differences. Subst Use Misuse. 2020;55:928–936. 10.1080/10826084.2020.1713818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.This is Not About Drugs. Overdose Lifeline. Accessed 06.20.20 https://www.overdoselifeline.org/opioid-heroin-prevention-education-program.html, 2020.
  • 27.Patry E, Bratberg JP, Buchanan A, Paiva AL, Balestrieri S, Matson KL. Rx for addiction and medication safety: an evaluation of teen education for opioid misuse prevention. Res Soc Adm Pharm. 2019;15:917–924. 10.1016/j.sapharm.2018.07.006. [DOI] [PubMed] [Google Scholar]
  • 28.Abraham O, LeMay S, Bittner S, Thakur T, Stafford H, Brown R. Investigating serious games that incorporate medication use for patients: systematic literature review. JMIR Serious Games. 2020;8:e16096. Published 2020 Apr 29. 10.2196/16096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Abraham O, Thakur T, Brasel K, Norton D, Rosenberger CA. Development of the Adolescent Opioid Safety and Learning (AOSL) scale using exploratory factor analysis [published online ahead of print, 2021 Jun 12]. Res Soc Adm Pharm. 2021;S 1551–7411(21):209. 6. 10.1016/j.sapharm.2021.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Linnan S, Walsh-Fez A, Moberg P. Perceptions, Awareness, and Use of Substances in Wisconsin: Results of a Survey Conducted for the Wisconsin Strategic Prevention Framework Partnerships for Success 2015. University of Wisconsin Population Health Institute; February 2018. [Google Scholar]
  • 31.Cameron KA, Ross EL, Clayman ML, et al. Measuring patients’ self-efficacy in understanding and using prescription medication. Patient Educ Counsel. 2010;80: 372–376. 10.1016/j.pec.2010.06.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Guerin RJ, Toland MD, Okun AH, Rojas-Guyler L, Bernard AL. Using a modified theory of planned behavior to examine adolescents’ workplace safety and health knowledge, perceptions, and behavioral intention: a structural equation modeling approach. J Youth Adolesc. 2018;47:1595–1610. 10.1007/s10964-018-0847-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Admassu H, Tom S, Sealfon N, Gibson M, Pradel F. Maryland Public Opinion Survey on Opioids, 2015: Summary Report. Baltimore (MD): University of Maryland; 2015. Baltimore. [Google Scholar]
  • 34.Abraham O, Brothers A, Alexander DS, Carpenter DM. Pediatric medication use experiences and patient counseling in community pharmacies: perspectives of children and parents. J Am Pharmaceut Assoc. 2003;57(1):38–46. e2. 10.1016/j.japh.2016.08.019. [DOI] [PubMed] [Google Scholar]
  • 35.Carpenter DM, Abraham O, Alexander DS, Horowitz K. Counseling of children and adolescents in community pharmacies: results from a 14-day observational study. J Am Pharmaceut Assoc. 2003;56(3):266–269. 2016. 10.1016/j.japh.2016.03.001. [DOI] [PubMed] [Google Scholar]
  • 36.Cognitive Development in the Teen Years Stanford Children’s Health. [08.16.2021]. https://www.stanfordchildrens.org/en/topic/default?id=cognitive-development-90-P01594 Accessed.
  • 37.Kerridge BT, Saha TD, Chou SP, et al. Gender and nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions - III. Drug Alcohol Depend. 2015;156:47–56. 10.1016/j.drugalcdep.2015.08.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Sharma B, Bruner A, Barnett G, Fishman M. Opioid use disorders. Child Adolesc Psychiatr Clin N Am. 2016;25:473–487. 10.1016/j.chc.2016.03.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Winstanley EL, Stover AN. The impact of the opioid epidemic on children and adolescents. Clin Therapeut. 2019;41:1655–1662. 10.1016/j.clinthera.2019.06.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Hamers JP, Abu-Saad HH. Children’s pain at home following (adeno) tonsillectomy. Eur J Pain. 2002;6:213–219. 10.1053/eujp.2001.0326. [DOI] [PubMed] [Google Scholar]
  • 41.Elliott AL, Liu Y, Egan KL, Striley CW, Cottler LB. Exposure to medicines in the family medicine cabinet: is it a harbinger of later opioid dependence?. Subst Use Misuse. 2020;55:1709–1715. 10.1080/10826084.2020.1756856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Vadivelu N, Kai AM, Kodumudi V, Sramcik J, Kaye AD. The opioid crisis: a comprehensive overview. Curr Pain Headache Rep. 2018;22:16. 10.1007/s11916-018-0670-z. [DOI] [PubMed] [Google Scholar]
  • 43.Edlund MJ, Forman-Hoffman VL, Winder CR, et al. Opioid abuse and depression in adolescents: results from the national survey on drug use and health. Drug Alcohol Depend. 2015;152:131–138. 10.1016/j.drugalcdep.2015.04.010. [DOI] [PubMed] [Google Scholar]
  • 44.Griesler PC, Hu MC, Wall MM, Kandel DB. Nonmedical prescription opioid use by parents and adolescents in the US. Pediatrics. 2019;143:e20182354. 10.1542/peds.2018-2354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Beyene K, Aspden T, McNeill R, Sheridan J. Modifiable risk factors for prescription medicine sharing behaviours. Res Soc Adm Pharm. 2019;15:154–163. 10.1016/j.sapharm.2018.04.005. [DOI] [PubMed] [Google Scholar]
  • 46.Matson KL, Johnson PN, Tran V, Horton ER, Sterner-Allison J. Advocacy committee on behalf of pediatric pharmacy advocacy group. Opioid use in children. J Pediatr Pharmacol Therapeut. 2019;24(1):72–75. 10.5863/1551-6776-24.1.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Donaldson CD, Nakawaki B, Crano WD. Variations in parental monitoring and predictions of adolescent prescription opioid and stimulant misuse. Addict Behav. 2015;45:14–21. 10.1016/j.addbeh.2015.01.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Alonso-Fernandez C, Calvo A, Freire M, Martinez-Ortiz I, Fernandez-Manjon B. Systematizing game learning analytics for serious games. IEEE Global Engineering Education Conference (EDUCON). 2017;1111–1118. 10.1109/EDUCON.2017.7942988. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Due to the sensitive nature of the questions asked in this study, survey respondents were assured raw data would remain confidential and would not be shared.

RESOURCES